Erba Mannheim Showcases New Launches at MEDICA 2019
|
By LabMedica International staff writers Posted on 20 Nov 2019 |

Image: Electrolyte Analyser EC90 (Photo courtesy of Erba Mannheim)
Erba Mannheim (London, UK) showcased some exciting new launches and provided a preview of NEXUS, its future generation of hematology, chemistry and immunoassay systems, at the MEDICA 2019 International Trade Fair on November 18-21 in Düsseldorf, Germany. MEDICA is the world's largest annual medical technology trade fair and provides the medical device industry with a central market for innovative products and systems that result in an important contribution to the efficiency and quality of patient care. The combination of product shows with international congresses, forums, as well as expert workshops, and the exchange of professional views make MEDICA a meeting point for international professionals from various fields in the medical sector.
Erba Mannheim is an emerging player in the global IVD market and offers innovative solutions for lab diagnostics. At MEDICA 2019, the company showcased some of its new launches, including its new EC90 electrolyte analyzer with maintenance-free electrodes in an all-in-one sensor cartridge that is aimed at labs of all sizes. The EC 90 directly measures Na+, Cl-, K+ and Ca2+ from whole blood, plasma, serum and pre-diluted urine using a sensor incorporating thick film technology. The ‘plug and play’ sensor cartridge is integrated into a new reagent pack capable of performing up to 3,000 samples, with a market leading on-board lifetime of three months. No maintenance or cleaning of the pack is required, and waste is self-contained. The EC 90 can analyze samples in 35 seconds, with a typical throughput of 90 samples/hour, and has 35µL and 70µL sample volume measuring modes. Results can be given with a resolution of 0.1mmol/L for Na+ and Cl-, 0.01mmol/L for K+ and Ca2+, and are reproducible with CV< 1%. Small and lightweight (337 x 273 x 422mm, <8kg), the EC 90 features an 8.5-inch color touchscreen display, LIS connectivity, automatic calibration, two USB ports, on-board 24 column thermal printer and a serial port.
Erba Mannheim also showcased the ELAN 30s, a new fully automated compact benchtop ELISA microstrip processor with easy-to-use software, including QC reports and the ability to perform six different tests simultaneously. ELAN 30s eliminates the need for a ELISA reader and washer, making it the ultimate automated solution for labs with small, medium and varied ELISA workloads.
Also on display at this year’s MEDICA was Erba Mannheim’s XL 200 fully automated random access clinical chemistry analyzer with a throughput of 200 tests/hour (photometric test) and 400 tests/hour with ISE (Na/K/Cl/Li). The XL 200 offers 30 position reagent tray with on-board cooling, convenient software and an extensive quality control menu.
At MEDICA 2019, Erba Mannheim provided a preview of its new NEXUS advanced automation range. NEXUS will provide labs with a modular solution designed to deliver mid-scale, advanced-automation across immunology, clinical chemistry and hematology, using a powerful array of technology such as advanced imaging, artificial intelligence, thick film ISE and high sensitivity magnetic beads for CLIA analysis.
Related Links:
Erba Mannheim
Erba Mannheim is an emerging player in the global IVD market and offers innovative solutions for lab diagnostics. At MEDICA 2019, the company showcased some of its new launches, including its new EC90 electrolyte analyzer with maintenance-free electrodes in an all-in-one sensor cartridge that is aimed at labs of all sizes. The EC 90 directly measures Na+, Cl-, K+ and Ca2+ from whole blood, plasma, serum and pre-diluted urine using a sensor incorporating thick film technology. The ‘plug and play’ sensor cartridge is integrated into a new reagent pack capable of performing up to 3,000 samples, with a market leading on-board lifetime of three months. No maintenance or cleaning of the pack is required, and waste is self-contained. The EC 90 can analyze samples in 35 seconds, with a typical throughput of 90 samples/hour, and has 35µL and 70µL sample volume measuring modes. Results can be given with a resolution of 0.1mmol/L for Na+ and Cl-, 0.01mmol/L for K+ and Ca2+, and are reproducible with CV< 1%. Small and lightweight (337 x 273 x 422mm, <8kg), the EC 90 features an 8.5-inch color touchscreen display, LIS connectivity, automatic calibration, two USB ports, on-board 24 column thermal printer and a serial port.
Erba Mannheim also showcased the ELAN 30s, a new fully automated compact benchtop ELISA microstrip processor with easy-to-use software, including QC reports and the ability to perform six different tests simultaneously. ELAN 30s eliminates the need for a ELISA reader and washer, making it the ultimate automated solution for labs with small, medium and varied ELISA workloads.
Also on display at this year’s MEDICA was Erba Mannheim’s XL 200 fully automated random access clinical chemistry analyzer with a throughput of 200 tests/hour (photometric test) and 400 tests/hour with ISE (Na/K/Cl/Li). The XL 200 offers 30 position reagent tray with on-board cooling, convenient software and an extensive quality control menu.
At MEDICA 2019, Erba Mannheim provided a preview of its new NEXUS advanced automation range. NEXUS will provide labs with a modular solution designed to deliver mid-scale, advanced-automation across immunology, clinical chemistry and hematology, using a powerful array of technology such as advanced imaging, artificial intelligence, thick film ISE and high sensitivity magnetic beads for CLIA analysis.
Related Links:
Erba Mannheim
Latest Medica 2019 News
- Mast Group Introduces New MAST CARBA PAcE for Rapid Carbapenemase Detection
- DRG Instruments Demonstrates DRG:HYBRID-XL Fully Automated Lab Analyzer
- Diatron Introduces New Aquila 5Dretic 5-Part Differential Hematology Analyzer
- Alifax S.r.l. Highlights First Automated System for Bacterial Culture and Susceptibility Testing
- EUROIMMUN Showcases Immunoassay Testing Products at MEDICA 2019
- Diconex S.A. Exhibits InCCA Intelligent Clinical Chemistry Analyzer at MEDICA 2019
- Chembio Diagnostics Showcases New DPP Line of Rapid Tests at MEDICA 2019
- DYNEX Demonstrates DYNABLOT Automatic Analyzer for Immunoblot and Westernblot Methods
- Systec Launches New and Improved HX-150 Autoclave at MEDICA 2019
- TaiDoc Showcases Multi-Parameter Monitoring Systems and Advanced Devices
- IDS Exhibits Next Generation Automated Immunoanalyzer IDS-i10 at MEDICA 2019
- JEOL Ltd. Introduces BioMajesty Series of Clinical Chemistry Analyzers at MEDICA 2019
- EKF Diagnostics Showcases Full Product Range at MEDICA 2019
Channels
Clinical Chemistry
view channel
Lollipop-Inspired Device Measures Acetaminophen Levels in Saliva
Acetaminophen is used in many over-the-counter pain relievers, cold and flu products, and other medications. Excess dosing can cause serious side effects, including liver damage, and children may be at... Read more
New Insights Into Fetal DNA Could Improve Non-Invasive Prenatal Testing
Non-invasive prenatal testing is widely used to screen pregnancies for genetic conditions by analyzing DNA fragments in maternal blood. Although it offers a safer alternative to invasive procedures such... Read moreMolecular Diagnostics
view channel
Tumor Markers Help Predict Response to Less Intensive HER2+ Chemotherapy
HER2-positive breast cancer is commonly treated before surgery with multiagent chemotherapy and HER2-targeted drugs. In early-stage disease, a key challenge is identifying which tumors may respond well... Read more
Expanded Sequencing Panel Supports Myeloid Malignancy Variant Profiling
Myeloid malignancies require molecular profiling to detect variants relevant to disease characterization and research. FLT3 internal tandem duplications occur in an estimated 20–30% of de novo acute myeloid... Read moreHematology
view channel
New Donor Genetic Marker May Help Predict Stem Cell Transplant Success
Donor selection for hematopoietic stem cell transplantation plays a major role in relapse risk and survival for patients with blood cancers and other blood disorders. Despite advances in genotyping, uncertainty... Read more
Updated Ferritin Thresholds Improve Detection of Iron Deficiency
Iron deficiency is one of the most common health conditions worldwide, yet its nonspecific symptoms can delay diagnosis for months. Variation in testing practices and ferritin thresholds may contribute... Read moreImmunology
view channel
New Web-Based Platform Helps Autoimmune Laboratories Manage Testing Complexity
Autoimmune disease testing often requires laboratories to coordinate results across multiple instruments, manual microscopy, and patient histories. As testing volumes and workflow complexity increase,... Read more
Routine Newborn Blood Spots Can Measure GBS Antibody Levels
Group B Streptococcus (GBS) can cause serious infections in newborns. Protecting infants remains challenging because immune protection may depend on antibodies transferred from mother to baby before birth.... Read moreMicrobiology
view channel
Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis
Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more
Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification
Mycobacterial infections are difficult to diagnose because closely related species can have different clinical and therapeutic implications. Nontuberculous mycobacteria (NTM) are increasingly recognized... Read more
Genomic Workflow Identifies Fungal Pathogens Before Blood Cultures Turn Positive
Fungal bloodstream infections pose a major threat to hospitalized patients. Candida species cause most invasive fungal infections worldwide and are among the leading causes of hospital-acquired bloodstream... Read more
FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample
Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read morePathology
view channel
Rapid Mass Spectrometry Test May Aid Glioma Margin Decisions
Glioma brain tumors are highly infiltrative and can extend into nearby healthy brain tissue, making tumor margins difficult to define during surgery. Residual tumor cells may contribute to recurrence and... Read more
Genomic Classifier Predicts Benefit From Adding Hormone Therapy to Salvage Prostate Radiation
Men who have undergone prostatectomy for prostate cancer may later develop a detectable or rising prostate-specific antigen, prompting salvage radiation therapy. A key challenge is determining who is most... Read moreTechnology
view channelLaser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns
Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more
Laser-Enhanced Assay Boosts Sensitivity for Colorectal Cancer Biomarker Detection
Colorectal cancer is the third most commonly diagnosed cancer and the second leading cause of cancer-related death worldwide. Early detection remains critical, but cancer biomarkers can produce only faint... Read moreIndustry
view channel
Collaboration Advances Automated Benchtop Platform for Routine Blood Testing
Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Expanded Partnership Supports AI Biomarker Validation and Clinical Trial Deployment
CellCarta (Montreal, Canada) and Imagene AI (Miami, FL, USA) have expanded their collaboration to provide biopharma companies with a coordinated pathway for biomarker strategy, assay development, validation,... Read more
Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection
Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more








